1M6MYTD1Y5YMAX
Loading quotes...
Forecast
There is no analyst data available for this company.
News Go to news feed
Gentian Diagnostics posts profit and increases revenue in the quarter
Gentian Diagnostics reports for the quarter ending 30 June 2026 a profit of 0.29 NOK per share after -0.13 NOK a year earlier. Revenue rose 14.23% to 49.8 million NOK versus 43.6 million NOK in the year-ago quarter. The figures show an operational recovery compared with the previous year. » More on finanzen.net
Historical dividends Dividends
All dividend metrics All metricsFinancials
| (EUR) | Jun 2026 | |
|---|---|---|
| Revenue | 4.4M | 19.98% |
| Gross profit | 2.44M | 49.61% |
| Net profit | 390.75K | 336.56% |
| EBITDA | 857.51K | 399.54% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €56.5M |
Number of shares | 15.46M |
52-week high/low | €5.52 - €3.08 |
Dividend yield | 1.53% |
Dividends TTM | €0.0556 |
Beta | 0.45 |
P/E ratio | -72.18 |
PEG ratio | 0.48 |
P/B ratio | 3.36 |
P/S ratio | 3.37 |
Company profile
| Name | GENTIAN DIAGNOST. NO -,01 |
| CEO | Matti Heinonen |
| Employees | 64 |
Ticker symbols
| Exchange | Symbol |
|---|---|
Frankfurt | 6FK.F |
Düsseldorf | 6FK.DU |
Discover assets
Shareholders of GENTIAN DIAGNOST. NO -,01 also invest in the following assets
